Deerfield Management Company, L.P. (Series C) Ideaya Biosciences, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,915,311 shares of IDYA stock, worth $92.4 Million. This represents 1.89% of its overall portfolio holdings.
Number of Shares
3,915,311
Previous 3,267,551
19.82%
Holding current value
$92.4 Million
Previous $53.5 Million
53.77%
% of portfolio
1.89%
Previous 1.35%
Shares
11 transactions
Others Institutions Holding IDYA
# of Institutions
219Shares Held
83.4MCall Options Held
28.7KPut Options Held
132K-
Black Rock Inc. New York, NY6.81MShares$161 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.55MShares$155 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.21MShares$146 Million0.07% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.03MShares$119 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.94MShares$117 Million0.0% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.13B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...